Overview

Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma

Status:
Recruiting
Trial end date:
2023-02-08
Target enrollment:
Participant gender:
Summary
Relapses free survival will be evaluated as efficacy of carbon ions radiation therapy released before surgery.
Phase:
Phase 2
Details
Lead Sponsor:
CNAO National Center of Oncological Hadrontherapy
Collaborator:
Foundation IRCCS San Matteo Hospital
Treatments:
Fluorouracil
Irinotecan
Oxaliplatin
Pancreatin
Pancrelipase